Literature DB >> 30679872

Changes in macular drusen parameters preceding the development of neovascular age-related macular degeneration.

Ali Lamin1,2, Adam M Dubis1,2, Sobha Sivaprasad3,4.   

Abstract

PURPOSE: To assess the rate of change in macular drusen load in fellow eyes of patients with unilateral neovascular age-related macular degeneration (AMD) to evaluate whether the change in drusen load determines the onset and type of choroidal neovascularisation (CNV).
METHODS: Subjects with unilateral neovascular AMD with a minimum of 2 years follow-up were identified retrospectively from the hospital electronic database. Drusen count, area and volume measurements at the macula of the contralateral eye were recorded using the commercial software on the Topcon 3D OCT-2000 devices over the previous 2 years. The mean rate of change of these parameters over time was compared between fellow eyes that converted to various CNV subtypes and those that did not.
RESULTS: Two hundred forty-eight patients met the inclusion criteria. Of these patients, 179 patients did not progress to neovascular AMD (Group 1) while 69 patients converted (Group 2) at the end of 2 years follow up. Mean drusen volumes and drusen areas increased significantly in Group 2 in the 2nd year by 0.031 mm3 (p < 0.001) and 0.572 mm2 (p = 0.002), respectively. However, there was no difference in the rate of change between the two groups at year 1. Furthermore, for each 0.1 mm increase in the cubed root of baseline mean drusen volume increases the odds of progressing to CNV by 40% (95% CI 1.2-1.6; p < 0.001). The increase in drusen volume was higher in the occult CNV group compared to classic CNV (p = 0.048).
CONCLUSION: A significant increase in mean drusen volume occurs in eyes in the preceding 12 months prior to conversion to neovascular AMD and this change is more significant in eyes with occult CNV.

Entities:  

Mesh:

Year:  2019        PMID: 30679872      PMCID: PMC6707230          DOI: 10.1038/s41433-019-0338-x

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

1.  Performance of drusen detection by spectral-domain optical coherence tomography.

Authors:  Ferdinand G Schlanitz; Christian Ahlers; Stefan Sacu; Christopher Schütze; Marcos Rodriguez; Sabine Schriefl; Isabelle Golbaz; Tobias Spalek; Geraldine Stock; Ursula Schmidt-Erfurth
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-12       Impact factor: 4.799

2.  Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography.

Authors:  Maciej Wojtkowski; Vivek Srinivasan; James G Fujimoto; Tony Ko; Joel S Schuman; Andrzej Kowalczyk; Jay S Duker
Journal:  Ophthalmology       Date:  2005-10       Impact factor: 12.079

3.  Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography.

Authors:  Zohar Yehoshua; Fenghua Wang; Philip J Rosenfeld; Fernando M Penha; William J Feuer; Giovanni Gregori
Journal:  Ophthalmology       Date:  2011-07-02       Impact factor: 12.079

Review 4.  Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration.

Authors:  Karen B Schaal; Philip J Rosenfeld; Giovanni Gregori; Zohar Yehoshua; William J Feuer
Journal:  Ophthalmology       Date:  2016-03-05       Impact factor: 12.079

5.  Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs.

Authors:  Nieraj Jain; Sina Farsiu; Aziz A Khanifar; Srilaxmi Bearelly; R Theodore Smith; Joseph A Izatt; Cynthia A Toth
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-14       Impact factor: 4.799

6.  Histologic features of the early stages of age-related macular degeneration. A statistical analysis.

Authors:  T L van der Schaft; C M Mooy; W C de Bruijn; F G Oron; P G Mulder; P T de Jong
Journal:  Ophthalmology       Date:  1992-02       Impact factor: 12.079

7.  Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration.

Authors:  Giovanni Gregori; Fenghua Wang; Philip J Rosenfeld; Zohar Yehoshua; Ninel Z Gregori; Brandon J Lujan; Carmen A Puliafito; William J Feuer
Journal:  Ophthalmology       Date:  2011-03-09       Impact factor: 12.079

8.  Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1993-09

9.  Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration.

Authors:  Francisco A Folgar; Eric L Yuan; Monica B Sevilla; Stephanie J Chiu; Sina Farsiu; Emily Y Chew; Cynthia A Toth
Journal:  Ophthalmology       Date:  2015-11-12       Impact factor: 12.079

10.  Clinical classification of age-related macular degeneration.

Authors:  Frederick L Ferris; C P Wilkinson; Alan Bird; Usha Chakravarthy; Emily Chew; Karl Csaky; SriniVas R Sadda
Journal:  Ophthalmology       Date:  2013-01-16       Impact factor: 12.079

View more
  3 in total

1.  To Peel or Not to Peel: Pars Plana Vitrectomy with Macular Membrane Peel in Eyes with Abnormalities of Vitreomacular Interface and Coexisting Dry Age-Related Macular Degeneration.

Authors:  Olga Furashova; Katrin Engelmann
Journal:  Clin Ophthalmol       Date:  2020-02-11

2.  Multispectral pattern recognition measures change in drusen area in age-related macular degeneration with high congruency to expert graders.

Authors:  Judy Nam; Angelica Ly; Michael Kalloniatis; Lisa Nivison-Smith
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

Review 3.  Potential Therapeutic Benefit of NAD+ Supplementation for Glaucoma and Age-Related Macular Degeneration.

Authors:  Gloria Cimaglia; Marcela Votruba; James E Morgan; Helder André; Pete A Williams
Journal:  Nutrients       Date:  2020-09-19       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.